$43.45
0.010.02%
Last update: 10:32 AM
15 minutes delayed
Comments
Loading...
Cerevel Therapeutics Hldg
CERENASDAQ
Cerevel Therapeutics Hldg (NASDAQ:CERE) Stock, Insider Trading Activity
Cerevel Therapeutics Hldg: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Cerevel Therapeutics Holdings Inc Insiders Doing?
At Cerevel Therapeutics Holdings Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of - shares worth -, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Cerevel Therapeutics Holdings Inc
Institutional Shares Held
28.753M
Institutional Percentage Held
15.8%
| Jul 03, 2024 | ANTHONY COLES | — | 0.00 | $22.34 | -$942.03K | SELL-OPTIONS | 0.00% | 25.93K | Jul 01 | View |
| Jun 05, 2024 | ANTHONY COLES | — | 0.00 | $22.06 | -$1.86M | SELL-OPTIONS | 0.00% | 15.64K | Jun 03 | View |
| May 14, 2024 | ANTHONY COLES | — | 0.00 | $22.80 | -$1.93M | SELL-OPTIONS | 0.00% | 15.64K | May 10 | View |
| Apr 03, 2024 | ANTHONY COLES | — | 0.00 | $22.92 | -$1.94M | SELL-OPTIONS | 0.00% | 15.64K | Apr 01 | View |
| Mar 06, 2024 | ANTHONY COLES | — | 0.00 | $22.26 | -$1.88M | SELL-OPTIONS | 0.00% | 15.64K | Mar 04 | View |
| Mar 04, 2024 | ANTHONY COLES | — | 0.00 | $22.33 | -$1.88M | SELL-OPTIONS | 0.00% | 15.64K | Feb 29 | View |
| Feb 08, 2024 | John Renger | CHIEF SCIENTIFIC OFFICER | 2.86K | $41.54 | -$89.78K | SELL-OPTIONS | 81.43% | 6.37K | Feb 06 - Feb 07 | View |
| Feb 08, 2024 | ANTHONY COLES | — | 12.93K | $41.54 | -$104.11K | SELL-OPTIONS | 478.33% | 15.64K | Feb 06 - Feb 07 | View |
| Jan 04, 2024 | ANTHONY COLES | — | 0.00 | $22.87 | -$1.94M | SELL-OPTIONS | 0.00% | 2.70K | Jan 02 | View |
| Dec 28, 2023 | Ramiro Sanchez | CHIEF MEDICAL OFFICER | 0.00 | $22.98 | -$389.70K | SELL-OPTIONS | 0.00% | 14.67K | Dec 26 | View |
| Dec 27, 2023 | Kenneth DiPietro | CHIEF HUMAN RESOURCES OFFICER | 0.00 | $22.48 | -$303.61K | SELL-OPTIONS | 0.00% | 24.66K | Dec 22 | View |
| Dec 21, 2023 | Mark Bodenrader | SEE REMARKS | 11.39K | $41.42 | -$326.79K | SELL-OPTIONS | 180.04% | 17.72K | Dec 19 - Dec 20 | View |
| Dec 21, 2023 | Kenneth DiPietro | CHIEF HUMAN RESOURCES OFFICER | 7.66K | $41.42 | -$259.14K | SELL-OPTIONS | 45.03% | 24.66K | Dec 19 - Dec 20 | View |
| Dec 21, 2023 | Scott Akamine | CHIEF LEGAL OFFICER | 6.72K | $41.42 | -$292.94K | SELL-OPTIONS | 1310.72% | 7.24K | Dec 19 - Dec 20 | View |
| Dec 21, 2023 | Ramiro Sanchez | CHIEF MEDICAL OFFICER | 14.67K | $41.42 | -$420.53K | SELL-OPTIONS | ∞ | 14.67K | Dec 19 - Dec 20 | View |
| Dec 21, 2023 | Susan ALTSCHULLER | CHIEF FINANCIAL OFFICER | 16.91K | $41.42 | -$571.97K | SELL-OPTIONS | ∞ | 16.91K | Dec 19 - Dec 20 | View |
| Dec 21, 2023 | Kathleen Tregoning | SEE REMARKS | 7.52K | $41.42 | -$260.47K | SELL-OPTIONS | ∞ | 7.52K | Dec 19 - Dec 20 | View |
| Dec 19, 2023 | Ramiro Sanchez | CHIEF MEDICAL OFFICER | 0.00 | $25.63 | -$236.29K | SELL-OPTIONS | 0.00% | 0.00 | Dec 15 | View |
| Dec 11, 2023 | Ramiro Sanchez | CHIEF MEDICAL OFFICER | 0.00 | $22.43 | -$378.70K | SELL-OPTIONS | 0.00% | 0.00 | Dec 07 | View |
| Dec 07, 2023 | Scott Akamine | CHIEF LEGAL OFFICER | 0.00 | $25.91 | -$445.73K | SELL-OPTIONS | 0.00% | 513.00 | Dec 05 - Dec 07 | View |
| Nov 16, 2023 | ANTHONY COLES | — | 0.00 | $14.31 | -$493.57K | SELL-OPTIONS | 0.00% | 2.70K | Nov 14 | View |
| Nov 09, 2023 | ANTHONY COLES | — | 0.00 | $14.26 | -$584.96K | SELL-OPTIONS | 0.00% | 2.70K | Nov 07 - Nov 08 | View |
| Nov 06, 2023 | ANTHONY COLES | — | 0.00 | $14.42 | -$2.18M | SELL-OPTIONS | 0.00% | 2.70K | Nov 02 - Nov 03 | View |
| Nov 03, 2023 | DEVAL PATRICK | — | 0.00 | $18.81 | -$373.01K | SELL-OPTIONS | 0.00% | 3.28K | Nov 01 | View |
| Oct 18, 2023 | Christopher Gordon | DIRECTOR | 5.48M | $22.81 | $125.00M | BUY | 9.10% | 65.68M | Oct 16 | View |
| Oct 18, 2023 | Adam Koppel | DIRECTOR | 5.48M | $22.81 | $125.00M | BUY | 9.10% | 65.68M | Oct 16 | View |
| Oct 18, 2023 | BAIN CAPITAL INVESTORS LLCBC Perception Holdings LPBCPE Perception GP LLCBain Capital Fund XII LPBain Capital Partners XII LLC | 10% OWNER | 5.48M | $22.81 | $125.00M | BUY | 9.10% | 65.68M | Oct 16 | View |
| Oct 17, 2023 | PERCEPTIVE ADVISORS LLCPERCEPTIVE LIFE SCIENCES MASTER FUND LTDJOSEPH EDELMAN | DIRECTOR | 876.81K | $22.81 | $20.00M | BUY | 8.69% | 10.97M | Oct 16 | View |
| Sep 08, 2023 | ANTHONY COLES | — | 0.00 | $13.78 | -$1.03M | SELL-OPTIONS | 0.00% | 2.70K | Sep 07 | View |
| Aug 07, 2023 | Ronald Renaud JR | PRESIDENT & CEO | 83.86K | $23.96 | $2.01M | BUY | ∞ | 83.86K | Aug 03 | View |
| Aug 07, 2023 | Paul Burgess | SEE REMARKS | 21.88K | $22.93 | $501.79K | BUY | ∞ | 21.88K | Aug 04 | View |
| Jul 13, 2023 | ANTHONY COLES | — | 0.00 | $16.76 | -$1.33M | SELL-OPTIONS | 0.00% | 2.70K | Jul 11 | View |
| Jun 20, 2023 | MARIJN DEKKERS | — | -200.00K | $34.43 | -$6.89M | SELL | -31.54% | 434.15K | Jun 15 | View |
| Jun 05, 2023 | ANTHONY COLES | CEO AND CHAIRPERSON | 0.00 | $18.05 | -$1.46M | SELL-OPTIONS | 0.00% | 2.70K | Jun 01 | View |
| Jun 05, 2023 | Mark Bodenrader | SEE REMARKS | 2.84K | $32.95 | -$62.44K | SELL-OPTIONS | 105.74% | 5.52K | Jun 01 - Jun 02 | View |
| May 08, 2023 | ANTHONY COLES | CEO AND CHAIRPERSON | 0.00 | $17.48 | -$1.40M | SELL-OPTIONS | 0.00% | 2.70K | May 04 | View |
| Apr 13, 2023 | ANTHONY COLES | CEO AND CHAIRPERSON | 0.00 | $14.28 | -$1.08M | SELL-OPTIONS | 0.00% | 2.70K | Apr 11 | View |
| Mar 06, 2023 | ANTHONY COLES | CEO AND CHAIRPERSON | 0.00 | $15.31 | -$1.18M | SELL-OPTIONS | 0.00% | 2.70K | Mar 02 - Mar 03 | View |
| Feb 08, 2023 | ANTHONY COLES | CEO AND CHAIRPERSON | 0.00 | $18.31 | -$1.48M | SELL-OPTIONS | 0.00% | 2.70K | Feb 07 | View |
| Jan 06, 2023 | ANTHONY COLES | CEO AND CHAIRPERSON | 0.00 | $16.72 | -$1.32M | SELL-OPTIONS | 0.00% | 2.70K | Jan 05 | View |
| Dec 13, 2022 | ANTHONY COLES | CEO AND CHAIRPERSON | 0.00 | $15.08 | -$1.16M | SELL-OPTIONS | 0.00% | 2.70K | Dec 09 | View |
| Nov 03, 2022 | John Renger | CHIEF SCIENTIFIC OFFICER | 0.00 | $18.78 | -$560.93K | SELL-OPTIONS | 0.00% | 2.70K | Nov 01 | View |
| Oct 06, 2022 | John Renger | CHIEF SCIENTIFIC OFFICER | 0.00 | $18.78 | -$560.92K | SELL-OPTIONS | 0.00% | 2.70K | Oct 04 | View |
| Sep 14, 2022 | DEVAL PATRICK | DIRECTOR | 0.00 | $21.70 | -$866.38K | SELL-OPTIONS | 0.00% | 0.00 | Sep 12 | View |
| Sep 12, 2022 | Abraham Ceesay | PRESIDENT | 0.00 | $22.84 | -$371.33K | SELL-OPTIONS | 0.00% | 0.00 | Sep 08 | View |
| Aug 24, 2022 | Abraham Ceesay | PRESIDENT | 0.00 | $22.84 | -$185.66K | SELL-OPTIONS | 0.00% | 0.00 | Aug 22 | View |
| Aug 17, 2022 | Abraham Ceesay | PRESIDENT | 0.00 | $23.64 | -$201.25K | SELL-OPTIONS | 0.00% | 0.00 | Aug 15 | View |
| Aug 12, 2022 | John Renger | CHIEF SCIENTIFIC OFFICER | 0.00 | $23.57 | -$1.86M | SELL-OPTIONS | 0.00% | 2.70K | Aug 10 | View |
| Aug 09, 2022 | John Renger | CHIEF SCIENTIFIC OFFICER | 0.00 | $18.88 | -$922.50K | SELL-OPTIONS | 0.00% | 2.70K | Aug 05 - Aug 08 | View |
| Aug 09, 2022 | Scott Akamine | CHIEF LEGAL OFFICER | 0.00 | $26.59 | -$268.30K | SELL-OPTIONS | 0.00% | 0.00 | Aug 08 | View |
| Aug 09, 2022 | Abraham Ceesay | PRESIDENT | 0.00 | $23.86 | -$1.23M | SELL-OPTIONS | 0.00% | 0.00 | Aug 05 - Aug 08 | View |
| Jul 22, 2022 | John Renger | CHIEF SCIENTIFIC OFFICER | 0.00 | $16.75 | -$662.50K | SELL-OPTIONS | 0.00% | 2.70K | Jul 20 | View |
| Jul 07, 2022 | John Renger | CHIEF SCIENTIFIC OFFICER | 0.00 | $16.80 | -$694.54K | SELL-OPTIONS | 0.00% | 2.70K | Jul 05 - Jul 06 | View |
| Apr 15, 2022 | John Renger | CHIEF SCIENTIFIC OFFICER | 0.00 | $19.07 | -$1.40M | SELL-OPTIONS | 0.00% | 1.98K | Apr 13 | View |
| Mar 31, 2022 | John Renger | CHIEF SCIENTIFIC OFFICER | 0.00 | $19.25 | -$315.00K | SELL-OPTIONS | 0.00% | 1.98K | Mar 29 | View |
| Mar 18, 2022 | John Renger | CHIEF SCIENTIFIC OFFICER | 0.00 | $17.31 | -$1.24M | SELL-OPTIONS | 0.00% | 1.98K | Mar 16 - Mar 18 | View |
| Mar 11, 2022 | John Renger | CHIEF SCIENTIFIC OFFICER | 0.00 | $18.42 | -$895.00K | SELL-OPTIONS | 0.00% | 1.98K | Mar 09 | View |
| Mar 04, 2022 | John Renger | CHIEF SCIENTIFIC OFFICER | 0.00 | $16.75 | -$662.50K | SELL-OPTIONS | 0.00% | 1.98K | Mar 02 | View |
| Feb 11, 2022 | John Renger | CHIEF SCIENTIFIC OFFICER | 0.00 | $16.75 | -$662.50K | SELL-OPTIONS | 0.00% | 1.98K | Feb 09 | View |
| Dec 28, 2021 | John Renger | CHIEF SCIENTIFIC OFFICER | 0.00 | $19.25 | -$315.03K | SELL-OPTIONS | 0.00% | 1.98K | Dec 23 - Dec 27 | View |
| Dec 23, 2021 | John Renger | CHIEF SCIENTIFIC OFFICER | 0.00 | $18.00 | -$211.70K | SELL-OPTIONS | 0.00% | 1.98K | Dec 21 | View |
| Dec 17, 2021 | John Renger | CHIEF SCIENTIFIC OFFICER | 0.00 | $17.18 | -$1.03M | SELL-OPTIONS | 0.00% | 1.98K | Dec 15 - Dec 17 | View |
| Nov 15, 2021 | John Renger | CHIEF SCIENTIFIC OFFICER | 0.00 | $21.68 | -$2.00M | SELL-OPTIONS | 0.00% | 0.00 | Nov 10 | View |
| Aug 31, 2021 | PERCEPTIVE ADVISORS LLCPERCEPTIVE LIFE SCIENCES MASTER FUND LTDJOSEPH EDELMAN | DIRECTOR | 68.05K | $30.23 | $2.06M | BUY | 1.36% | 5.09M | Aug 26 | View |
| Aug 25, 2021 | PERCEPTIVE ADVISORS LLCPERCEPTIVE LIFE SCIENCES MASTER FUND LTDJOSEPH EDELMAN | DIRECTOR | 175.59K | $27.53 | $4.83M | BUY | 3.63% | 5.02M | Aug 23 - Aug 25 | View |
| Jul 09, 2021 | PERCEPTIVE ADVISORS LLCPERCEPTIVE LIFE SCIENCES MASTER FUND LTDJOSEPH EDELMAN | DIRECTOR | 200.00K | $25.00 | $5.00M | BUY | 4.31% | 4.84M | Jul 07 | View |
| Jun 22, 2021 | Gabrielle Sulzberger | DIRECTOR | 21.08K | $13.06 | $275.36K | BUY | 147.75% | 35.35K | Jun 17 | View |
| Nov 12, 2020 | BAIN CAPITAL INVESTORS LLCBC Perception Holdings LPBCPE Perception GP LLCBain Capital Fund XII LPBain Capital Partners XII LLC | — | 332.29K | $10.30 | $3.42M | PURCHASE | 0.55% | 60.63M | Nov 09 | View |
| Nov 12, 2020 | Adam Koppel | — | 332.29K | $10.30 | $3.42M | PURCHASE | 0.55% | 60.63M | Nov 09 | View |
| Nov 12, 2020 | Christopher R Gordon | — | 332.29K | $10.30 | $3.42M | PURCHASE | 0.55% | 60.63M | Nov 09 | View |
| Oct 29, 2020 | PERCEPTIVE ADVISORS LLCPERCEPTIVE LIFE SCIENCES MASTER FUND LTDJOSEPH EDELMAN | — | 3.00M | $10.00 | $30.00M | PURCHASE | 1907.24% | 3.16M | Oct 27 | View |
| Oct 29, 2020 | Adam Koppel | — | 59.96M | $10.00 | $100.00M | ACQUISITION OR DISPOSITION | 17733.92% | 60.30M | Oct 27 | View |
| Oct 29, 2020 | BAIN CAPITAL INVESTORS LLCBC Perception Holdings LPBCPE Perception GP LLCBain Capital Fund XII LPBain Capital Partners XII LLC | — | 10.00M | $10.00 | $100.00M | PURCHASE | 19.88% | 60.30M | Oct 27 | View |
| Oct 29, 2020 | Christopher R Gordon | — | 59.96M | $10.00 | $100.00M | ACQUISITION OR DISPOSITION | 17733.92% | 60.30M | Oct 27 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.